porno izle
porno
asyabahis
women desperate to piss ava addams mom porn sa akin ang gabi
sisli escort mecidiyekoy escort
replica watches
Neodyum Miknatis
implant
porno

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the monthly archives: December 2020

We are pleased to present below all posts archived in 'December 2020'. If you still can't find what you are looking for, try using the search box.

Yourgene Health: COVID-19 update: approved provider for UK Government and response to new virus strain

 Yourgene, the international molecular diagnostics group, announces that Yourgene Genomic Services has been added to the UK Government’s approved COVID-19 private testing providers list for the Test to Release for International Travel scheme introduced on 15 December 2020 (“Test to Release”), and also for general coronavirus testing. The Company has also conducted in silico analysis studies into the effect of the new virus strain which suggests that the performance of its test will be unaffected.

Read the rest of entry »

Absolute Antibody: LSBIO acquires Absolute Antibody

LSBio , a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. and its sister company Kerafast. Terms of the transaction were not disclosed

Read the rest of entry »

OBN Digital CEO Briefing: What does 31 December 2020 mean for Life Sciences?

We recently invited four experts in IP, Employment, Regulatory and Grant Funding to tell us what we can expect from the end of the Brexit Transition and have summarised the points here for your easy reference.  

Read the rest of entry »

AMSBIO: Heparan Sulfate Products for COVID-19 Research

AMSBIO offer a wide range of Heparan Sulfate antibodies, enzymes, standards and ready-to-use Heparanase activity assays for researchers seeking to better understand COVID-19 and thereby to combat the pandemic.

Read the rest of entry »

Arctoris announces new Advisory Board members to further strengthen robotics-powered drug discovery

Arctoris Ltd, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Professor Khusru Asadullah MD, and Stanley Lapidus.

Read the rest of entry »

Absolute Antibody: International Consortium Awarded Eurostars Grant for the Development of First-in-class Treatment of Metastatic Cancer

ONA Therapeutics, Absolute Antibody and RIC - three leading European companies in the biotech landscape - have been awarded a Eurostars grant for a two-year project that will develop a proprietary biological drug with a unique mode of action for the treatment of various types of metastatic cancers

Read the rest of entry »

End of October 2020

AMSBIO: Heparan Sulfate products for COVID-19 research

AMSBIO offer a wide range of Heparan Sulfate antibodies, enzymes, standards and ready-to-use Heparanase activity assays for researchers seeking to better understand COVID-19 and thereby to combat the pandemic.

Read the rest of entry »

AMSBIO: Safeguarding Organoids Through Lockdown

AMSBIO reports how the internationally renowned Hans Clevers Lab at the Hubrecht Institute, Netherlands used their CELLBANKER® reagent when they needed to freeze down their organoids at short notice ahead of the COVID-19 spring lockdown.

Read the rest of entry »

Arecor’s Partner Inhibrx Exercises Its Option To License A New Formulation Developed By Arecor In Accordance With The Terms Of Formulation Development Agreement

Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its partner, Inhibrx, Inc., has exercised an option to license a novel enhanced formulation of Inhibrx’s proprietary therapeutic candidate, INBRX-101, developed by Arecor using the Company’s patented technology, Arestat™.   This is the first license under a multi-product development agreement between Inhibrx and Arecor.

Read the rest of entry »

Pages: Previous123NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.